Andrew D. Jones

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Andrew D. Jones
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew D. Jones:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovaBay Pharmaceuticals, Inc. CFO Common Stock 127,461 $230,704 $1.81 06 Dec 2021 Direct
EYENOVIA, INC. Chief Financial Officer Stock Option (right to buy) 200,000 30 Aug 2024 Direct

Insider Reports Filed by Andrew D. Jones

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EYEN EYENOVIA, INC. 30 Aug 2024 1 $0 4 Chief Financial Officer 03 Sep 2024, 08:07
EYEN EYENOVIA, INC. 30 Aug 2024 0 $0 3 Chief Financial Officer 03 Sep 2024, 08:05
NBY NovaBay Pharmaceuticals, Inc. 15 Feb 2023 0 $0 4 CFO 17 Feb 2023, 16:30
NBY NovaBay Pharmaceuticals, Inc. 03 Dec 2021 2 +$20,000 4 CFO 06 Dec 2021, 15:30
NBY NovaBay Pharmaceuticals, Inc. 04 May 2021 1 -$61,834 4 CFO 07 May 2021, 18:00